GSK stock rocketed Wednesday after the pharma titan raised its 2031 sales outlook to north of $50 billion.Please watch the ...
The FTSE 100 ( ^FTSE) and European stocks were lower on Wednesday as investors mulled disappointing US tech results and ...
AstraZeneca investors will look past another strong set of quarterly results on Thursday to focus on the main issue overhanging shares: an investigation of a top executive by authorities in China, one ...